跳至主要内容
临床试验/CTRI/2018/07/014844
CTRI/2018/07/014844已完成4 期

Effect of rosuvastatin on the anti-atherogenic effect of high density lipoprotein in pre and post menopausal women with type 2 diabetes mellitus

Sri Venkateswara Institute of Medical Sciences0 个研究点目标入组 29 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
29

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Newly diagnosed female patients with Type 2 Diabetes Mellitus aged between 40-70 years as per the revised ADA criteria (47):i.e
  • i) Fasting plasma glucose =126mg/dL (7.0mmol/L)
  • ii) 2 hour plasma glucose =200mg/dL (11.1mmol/L)
  • iii) Glycosylated hemoglobin (HbA1c) >6.5% (48 mmol/mol)
  • Patients with T2DM on oral antidiabetic treatment will be included.
  • Patients will be eligible of high intensity statin therapy as per ACC/AHA guidelines 2013 (48) i.e both
  • LDL Cholesterol >75 mg/dL and
  • A 10 year cardiovascular risk score = 7.5% on pooled cohort equation

排除标准

  • Male patients with type 2 Diabetes mellitus
  • Patients with other forms of Diabetes (T1DM, Gestational diabetes mellitus)
  • Those on insulin therapy
  • Thyroid disorders not on treatment
  • Those on pioglitazone
  • Those on hormone replacement therapy
  • Liver and kidney diseases
  • Other inflammatory diseases
  • Acute illness
  • Current smoking
  • On cholesterol lowering drugs
  • Pregnant and lactating women
  • Individuals who are not willing to participate

研究者

相似试验